Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)

NCT03113929 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03113929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
July 10, 2017
Completion date
December 1, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic liver disease